12:00 AM
Jul 01, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Spedra regulatory update

Vivus said the European Commission approved an MAA for Spedra avanafil to treat erectile dysfunction (ED). The fast-acting ...

Read the full 75 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >